It is expected that by 2026, the market size of recombinant collagen for cosmetics will reach 81 billion yuan ($11.27 billion).

In 2022, Jinbo Bio's operating revenue reached 390 million yuan ($56.75 million), an increase of 67.15% compared to 2021. The net profit...

The road to the IPO of Jinbo Bio is full of twists and turns. On September 29, Jinbo Bio-pharmaceutical released an announcement that it...